Tomáš Páleníček

4.5k total citations
84 papers, 2.4k citations indexed

About

Tomáš Páleníček is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Toxicology. According to data from OpenAlex, Tomáš Páleníček has authored 84 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cellular and Molecular Neuroscience, 43 papers in Clinical Psychology and 20 papers in Toxicology. Recurrent topics in Tomáš Páleníček's work include Neurotransmitter Receptor Influence on Behavior (48 papers), Psychedelics and Drug Studies (43 papers) and Forensic Toxicology and Drug Analysis (20 papers). Tomáš Páleníček is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (48 papers), Psychedelics and Drug Studies (43 papers) and Forensic Toxicology and Drug Analysis (20 papers). Tomáš Páleníček collaborates with scholars based in Czechia, Japan and Slovenia. Tomáš Páleníček's co-authors include Jiřı́ Horáček, Filip Tylš, Vĕra Bubeníková‐Valešová, Cyril Höschl, Marie Balı́ková, Colleen Dockery, Pavel Mohr, Tomáš Novák, Miloslav Kopeček and Rachel R. Horsley and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and International Journal of Molecular Sciences.

In The Last Decade

Tomáš Páleníček

76 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Páleníček Czechia 25 1.2k 1.0k 600 446 367 84 2.4k
John H. Halpern United States 23 814 0.7× 1.3k 1.3× 453 0.8× 674 1.5× 367 1.0× 38 2.3k
Yasmin Schmid Switzerland 27 1.2k 1.1× 2.1k 2.0× 446 0.7× 846 1.9× 472 1.3× 57 2.7k
Torsten Passie Germany 24 1.1k 0.9× 2.1k 2.0× 470 0.8× 1.1k 2.5× 297 0.8× 50 2.7k
R. Andrew Sewell United States 22 727 0.6× 546 0.5× 752 1.3× 278 0.6× 175 0.5× 36 1.8k
Leonard L. Howell United States 34 2.5k 2.1× 674 0.6× 584 1.0× 176 0.4× 477 1.3× 131 3.8k
Michael B. Gatch United States 30 1.5k 1.2× 722 0.7× 349 0.6× 276 0.6× 667 1.8× 80 2.5k
Euphrosyne Gouzoulis‐Mayfrank Germany 37 1.6k 1.4× 1.6k 1.6× 1.1k 1.9× 295 0.7× 1.1k 3.0× 138 3.6k
Valerie H. Curran United Kingdom 10 765 0.7× 1.1k 1.1× 639 1.1× 600 1.3× 179 0.5× 15 1.9k
Eef L. Theunissen Netherlands 32 914 0.8× 923 0.9× 1.7k 2.8× 347 0.8× 789 2.1× 94 3.0k
Alessandro Colasanti United Kingdom 27 923 0.8× 936 0.9× 289 0.5× 323 0.7× 60 0.2× 67 3.0k

Countries citing papers authored by Tomáš Páleníček

Since Specialization
Citations

This map shows the geographic impact of Tomáš Páleníček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Páleníček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Páleníček more than expected).

Fields of papers citing papers by Tomáš Páleníček

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Páleníček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Páleníček. The network helps show where Tomáš Páleníček may publish in the future.

Co-authorship network of co-authors of Tomáš Páleníček

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Páleníček. A scholar is included among the top collaborators of Tomáš Páleníček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Páleníček. Tomáš Páleníček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Štefková, Kristýna, Vladimír Mazoch, Klára Šíchová, et al.. (2025). The acute effects of methoxphenidine on behaviour and pharmacokinetics profile in animal model. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 137. 111285–111285.
2.
Šíchová, Klára, Vladimír Mazoch, Radek Jurok, et al.. (2025). Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium. Journal of Psychopharmacology. 39(9). 1023–1030. 1 indexed citations
3.
4.
Timmermann, Christopher, Genís Oña, Natasha L. Mason, et al.. (2025). Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. Neuroscience of Consciousness. 2025(1). niaf007–niaf007. 3 indexed citations
5.
Frischknecht, Renato, et al.. (2025). Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons. Journal of Neurochemistry. 169(3). e70020–e70020. 1 indexed citations
6.
Šíchová, Klára, et al.. (2022). Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN‐NBOMe. Addiction Biology. 27(5). e13216–e13216. 5 indexed citations
7.
Griškova-Bulanova, Inga, Filip Tylš, Kateřina Hájková, et al.. (2022). Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience. Journal of Personalized Medicine. 12(6). 1004–1004. 8 indexed citations
8.
Jurok, Radek, Silvie Rimpelová, Tereza Leonhardt, et al.. (2021). 25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C. elegans—Structure Determination and Synthesis of the Most Abundant Metabolites. Metabolites. 11(4). 212–212. 9 indexed citations
9.
Štefková, Kristýna, Wim Dehaen, Bronislav Jurásek, et al.. (2021). Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats. British Journal of Pharmacology. 179(1). 65–83. 6 indexed citations
10.
Šíchová, Klára, et al.. (2021). Effects of synthetic cathinone naphyrone in the conditioned place preference test – Evidence of its addictive potential. Behavioural Brain Research. 421. 113713–113713. 2 indexed citations
11.
Horsley, Rachel R., Klára Šíchová, Kristýna Štefková, et al.. (2020). Naphyrone (naphthylpyrovalerone): Pharmacokinetics, behavioural effects and thermoregulation in Wistar rats. Addiction Biology. 26(2). e12906–e12906. 9 indexed citations
12.
Páleníček, Tomáš, et al.. (2018). Electrical Source Imaging in Rats: Cortical EEG Performance and Limitations. 5. 45–46. 1 indexed citations
13.
14.
15.
Linhart, Igor, et al.. (2016). Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites. Xenobiotica. 47(6). 505–514. 5 indexed citations
16.
Šóš, P., et al.. (2013). Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.. PubMed. 34(4). 287–93. 160 indexed citations
17.
Horáček, Jiřı́, et al.. (2012). The influence of clonidine on oral ketamine-midazolam premedication in intellectually disabled patients indicated for dental procedures: double-blind comparison of two sedation regimes.. PubMed. 33(4). 380–4. 6 indexed citations
18.
Kubešová, Anna, et al.. (2012). Impact of psychotropic drugs on adult hippocampal neurogenesis. Neuroscience Research. 73(2). 93–98. 7 indexed citations
19.
20.
Horáček, Jiřı́, et al.. (2004). The effect of tryptophan depletion on the action of haloperidol in MK-801-treated rats. European Journal of Pharmacology. 502(1-2). 109–116. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John H. Halpern Breakdown of academic impact, for papers by Yasmin Schmid Breakdown of academic impact, for papers by Torsten Passie Breakdown of academic impact, for papers by R. Andrew Sewell Breakdown of academic impact, for papers by Leonard L. Howell Breakdown of academic impact, for papers by Michael B. Gatch Breakdown of academic impact, for papers by Euphrosyne Gouzoulis‐Mayfrank Breakdown of academic impact, for papers by Valerie H. Curran Breakdown of academic impact, for papers by Eef L. Theunissen Breakdown of academic impact, for papers by Alessandro Colasanti
Rankless by CCL
2026